The pharmaceutical industry is increasingly recognising the importance of eClinical technologies in clinical trial research and many firms are now seeking clinical research organisations (CROs) that offer these services, for faster access to clinical trials data.
eDiary 4.0 sports several new and updated features that the company claims will enable sponsors to gain access to patient reported outcomes even faster and more efficiently than before.
"The most important feature of the new software is that it is fully integrated with etrials' eClinical Suite and can also be implemented on a range of other software and devices, including mobile phones and PDAs," said Richard Piazza, vice president of product strategy at etrials.
"It has also been proven to result in greater patient compliance."
Available now, the new eDiary has an interface that can be modified and adapted to suit a wide variety of patient populations from pediatric to geriatric, said the firm.
The updated diary software also allows sponsors to control distribution of mid-study updates and segment the patient population with a more flexible configuration, the company said.
In addition, the etrials eDiary 4.0 is Windows-based, giving the technology a range of capabilities not available in PALM-based systems, including the ability to transfer data both wirelessly and/or wired with the same device, without modifying the software.
The firm also pointed out that the system is designed to be backward compatible, enabling sponsors to reprogram and redeploy devices for use in future studies in order to further cut costs.
Fully scaleable for all types of studies, including complicated multinational and multilingual studies, the technology also features a back-up system that continually duplicates study data for additional security.
Furthermore, etrials' new eDiary fully integrates the data collected with etrials' electronic data capture (EDC) without the need for additional data management, said the firm.